WST – West Pharmaceutical Services, Inc.
West Pharmaceutical Services, IWST
$239.26Name : West Pharmaceutical Services, I
Sector : Healthcare
Industry: Medical Instruments & Supplies
Mark. Cap: $17,204,539,392.00
EPSttm : 6.68
West Pharmaceutical Services, I
$239.26
0.00%$0.0000Float Short %
2.56
Margin Of Safety %
-13
Put/Call OI Ratio
0.65
EPS Next Q Diff
-0.06
EPS Last/This Y
0.01
EPS This/Next Y
0.79
Price
239.26
Target Price
314.73
Analyst Recom
1.59
Performance Q
13.79
Relative Volume
0.91
Beta
1.05
Ticker: WST
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | WST | 222.26 | 0.38 | 1.20 | 7206 |
| 2025-07-07 | WST | 221.64 | 0.38 | 0.67 | 7213 |
| 2025-07-08 | WST | 220.48 | 0.38 | 0.02 | 7220 |
| 2025-07-09 | WST | 226.21 | 0.36 | 0.40 | 7543 |
| 2025-07-10 | WST | 229.27 | 0.36 | 4.45 | 7546 |
| 2025-07-11 | WST | 227.04 | 0.38 | 0.55 | 7661 |
| 2025-07-14 | WST | 224.61 | 0.40 | 0.25 | 8134 |
| 2025-07-15 | WST | 221.54 | 0.40 | 0.07 | 8054 |
| 2025-07-16 | WST | 224.52 | 0.41 | 0.23 | 8024 |
| 2025-07-17 | WST | 221.63 | 0.40 | 0.85 | 8152 |
| 2025-07-18 | WST | 210.18 | 0.42 | 0.36 | 8265 |
| 2025-07-21 | WST | 210.11 | 0.40 | 2.40 | 7977 |
| 2025-07-22 | WST | 218.83 | 0.43 | 0.15 | 8192 |
| 2025-07-23 | WST | 227.46 | 0.43 | 0.51 | 8278 |
| 2025-07-24 | WST | 279.1 | 0.43 | 0.37 | 8681 |
| 2025-07-25 | WST | 263.44 | 0.65 | 3.84 | 9536 |
| 2025-07-28 | WST | 257.77 | 0.58 | 2.02 | 9141 |
| 2025-07-29 | WST | 252.92 | 0.58 | 0.75 | 9163 |
| 2025-07-30 | WST | 249.25 | 0.62 | 5.11 | 9866 |
| 2025-07-31 | WST | 239.08 | 0.68 | 2.49 | 10301 |
| 2025-08-01 | WST | 239.18 | 0.65 | 3.16 | 10140 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | WST | 222.26 | -1.1 | -30.8 | 6.28 |
| 2025-07-07 | WST | 221.60 | -1.1 | -35.0 | 6.28 |
| 2025-07-08 | WST | 220.48 | -1.1 | -35.8 | 6.28 |
| 2025-07-09 | WST | 226.18 | -1.1 | -19.4 | 6.28 |
| 2025-07-10 | WST | 229.23 | -1.1 | -26.1 | 6.28 |
| 2025-07-11 | WST | 227.18 | -1.1 | -31.0 | 6.28 |
| 2025-07-14 | WST | 224.50 | -1.1 | -39.7 | 6.28 |
| 2025-07-15 | WST | 221.05 | -1.1 | -41.6 | 6.28 |
| 2025-07-16 | WST | 224.35 | -1.1 | -25.3 | 6.28 |
| 2025-07-17 | WST | 221.59 | -1.1 | -40.1 | 6.28 |
| 2025-07-18 | WST | 211.01 | -1.1 | -59.2 | 6.28 |
| 2025-07-21 | WST | 210.14 | -1.1 | -35.3 | 6.28 |
| 2025-07-22 | WST | 218.74 | -1.1 | -11.1 | 6.28 |
| 2025-07-23 | WST | 227.31 | -1.1 | -12.6 | 6.28 |
| 2025-07-24 | WST | 279.10 | -0.8 | 89.8 | 6.27 |
| 2025-07-25 | WST | 263.51 | -8.9 | -63.5 | 6.77 |
| 2025-07-28 | WST | 257.42 | -8.9 | -50.3 | 6.77 |
| 2025-07-29 | WST | 252.94 | -8.9 | -36.6 | 6.76 |
| 2025-07-30 | WST | 249.21 | -8.9 | -33.9 | 6.76 |
| 2025-07-31 | WST | 239.26 | -9.1 | -48.5 | 6.76 |
| 2025-08-01 | WST | 239.26 | -9.1 | -25.5 | 6.76 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | WST | 0.00 | -0.03 | 2.92 |
| 2025-07-07 | WST | 0.00 | -0.02 | 2.92 |
| 2025-07-08 | WST | 0.00 | -0.02 | 2.92 |
| 2025-07-09 | WST | 0.00 | -0.02 | 2.92 |
| 2025-07-10 | WST | 0.00 | -0.02 | 2.92 |
| 2025-07-11 | WST | 0.00 | -0.02 | 3.00 |
| 2025-07-14 | WST | 0.00 | 0.32 | 3.00 |
| 2025-07-15 | WST | 0.00 | 0.32 | 3.00 |
| 2025-07-16 | WST | 0.00 | 0.32 | 3.00 |
| 2025-07-17 | WST | 0.00 | 0.32 | 3.00 |
| 2025-07-18 | WST | 0.00 | 0.32 | 3.00 |
| 2025-07-21 | WST | 0.00 | -0.24 | 3.00 |
| 2025-07-22 | WST | 0.00 | -0.24 | 3.00 |
| 2025-07-23 | WST | 0.00 | -0.24 | 3.00 |
| 2025-07-24 | WST | 0.00 | -0.24 | 3.00 |
| 2025-07-25 | WST | 0.00 | -0.24 | 2.57 |
| 2025-07-28 | WST | 0.00 | -1.21 | 2.56 |
| 2025-07-29 | WST | 0.00 | -1.21 | 2.56 |
| 2025-07-30 | WST | 0.00 | -1.21 | 2.56 |
| 2025-07-31 | WST | 0.00 | -1.21 | 2.56 |
| 2025-08-01 | WST | 0.00 | -1.21 | 2.56 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.84
Avg. EPS Est. Current Quarter
1.68
Avg. EPS Est. Next Quarter
1.78
Insider Transactions
Institutional Transactions
-1.21
Beta
1.05
Average Sales Estimate Current Quarter
788
Average Sales Estimate Next Quarter
796
Fair Value
207.04
Quality Score
96
Growth Score
70
Sentiment Score
51
Actual DrawDown %
49.7
Max Drawdown 5-Year %
-59.3
Target Price
314.73
P/E
35.84
Forward P/E
31.75
PEG
4.56
P/S
5.81
P/B
5.87
P/Free Cash Flow
50.01
EPS
6.68
Average EPS Est. Cur. Y
6.76
EPS Next Y. (Est.)
7.55
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
16.48
Relative Volume
0.91
Return on Equity vs Sector %
-7.1
Return on Equity vs Industry %
7.8
EPS 1 7Days Diff
0.5
EPS 1 30Days Diff
0.48
EBIT Estimation
-25.5
West Pharmaceutical Services, ISector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 10600
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
stock quote shares WST – West Pharmaceutical Services, Inc. Stock Price stock today
news today WST – West Pharmaceutical Services, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch WST – West Pharmaceutical Services, Inc. yahoo finance google finance
stock history WST – West Pharmaceutical Services, Inc. invest stock market
stock prices WST premarket after hours
ticker WST fair value insiders trading